(secondQuint)Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions.

 The study was designed to compare the rate and extent of absorption of cefprozil from the following products under fed condition: 1.

 CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL (Ranbaxy Laboratories Limited, India) 2.

 Cefzil (R) (CEFPROZIL) for oral suspension equivalent to 250mg/5mL anhydrous, cefprozil (Bristol-Myers Squibb Company USA) The bioequivalence of these formulations was assessed for cefprozil (Bristol-Myers Squibb Company, USA) Thirty -two subjects (32) were recruited for the study of which 16 were males and 16 were females.

 All of them completed the study.

 Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions@highlight

The study was conducted as an open-label, randomized, 2-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fed conditions